Cargando…
The HIV vaccine saga
The development of a vaccine that can prevent infection by the Human immunodeficiency virus or prevent the Acquired Immunodeficiency Syndrome has remained elusive despite 20 years of scientific effort. This "Commentary" analyzes the reasons that the development of a vaccine has been so dif...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC151598/ https://www.ncbi.nlm.nih.gov/pubmed/12628020 http://dx.doi.org/10.1186/1476-9433-2-1 |
_version_ | 1782120677598298112 |
---|---|
author | Smith, Kendall A |
author_facet | Smith, Kendall A |
author_sort | Smith, Kendall A |
collection | PubMed |
description | The development of a vaccine that can prevent infection by the Human immunodeficiency virus or prevent the Acquired Immunodeficiency Syndrome has remained elusive despite 20 years of scientific effort. This "Commentary" analyzes the reasons that the development of a vaccine has been so difficult, and proposes a plan to work towards an immunological approach to investigate the best vaccine candidates in the first world in individuals who are already infected, before taking the most promising vaccines to the developing world to attempt to prevent infection and disease. SAGA: (Old Norse) "a long, continued heroic story that is action-packed, but not especially romantic, and that is historical or legendary or both". |
format | Text |
id | pubmed-151598 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2003 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-1515982003-03-20 The HIV vaccine saga Smith, Kendall A Med Immunol Commentary The development of a vaccine that can prevent infection by the Human immunodeficiency virus or prevent the Acquired Immunodeficiency Syndrome has remained elusive despite 20 years of scientific effort. This "Commentary" analyzes the reasons that the development of a vaccine has been so difficult, and proposes a plan to work towards an immunological approach to investigate the best vaccine candidates in the first world in individuals who are already infected, before taking the most promising vaccines to the developing world to attempt to prevent infection and disease. SAGA: (Old Norse) "a long, continued heroic story that is action-packed, but not especially romantic, and that is historical or legendary or both". BioMed Central 2003-02-14 /pmc/articles/PMC151598/ /pubmed/12628020 http://dx.doi.org/10.1186/1476-9433-2-1 Text en Copyright © 2003 Smith; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL. |
spellingShingle | Commentary Smith, Kendall A The HIV vaccine saga |
title | The HIV vaccine saga |
title_full | The HIV vaccine saga |
title_fullStr | The HIV vaccine saga |
title_full_unstemmed | The HIV vaccine saga |
title_short | The HIV vaccine saga |
title_sort | hiv vaccine saga |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC151598/ https://www.ncbi.nlm.nih.gov/pubmed/12628020 http://dx.doi.org/10.1186/1476-9433-2-1 |
work_keys_str_mv | AT smithkendalla thehivvaccinesaga AT smithkendalla hivvaccinesaga |